Amanote Research
Register
Sign In
Mutations in the G 13 Pathway Promote GCB-DLBCL Progression
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2014-210
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
October 9, 2014
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
MEF2B Mutations Are Functionally Significant in DLBCL
Cancer Discovery
Oncology
Prognostic Value of Expression of Nuclear Factor Kappa-B/P65 in Non-GCB DLBCL Patients
Oncotarget
Oncology
miR-221/222 Promote Malignant Progression of Glioma Through Activation of the Akt Pathway
International Journal of Oncology
Cancer Research
Oncology
PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
Clinical Cancer Research
Cancer Research
Oncology
Macrophages Promote Polycystic Kidney Disease Progression
Kidney International
Nephrology
TP53 Mutations Promote Immunogenic Activity in Breast Cancer
Journal of Oncology
Oncology
McL1 and DEDD Promote Urothelial Carcinoma Progression
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
CircBANP Acts as a Sponge of Let-7a to Promote Gastric Cancer Progression via the FZD5/Wnt/β-catenin Pathway
RSC Advances
Chemistry
Chemical Engineering
Interaction of G 12 With G 13 and G Q Signaling Pathways
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary